Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Vital Harmony Rx
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Vital Harmony Rx: Check date not recorded
vs
Verdict46/ 100
Grade C · #543Vital Harmony Rx
Vital Harmony Rx is a telehealth platform offering compounded injectable GLP-1 therapy — semaglutide (GLP-1 + B12) and tirzepatide (GLP-1/GIP + B12) — plus a wellness-peptide menu of NAD+, sermorelin, and…
Visit Vital Harmony RxThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 46/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Vital Harmony Rx still earns its place — shoppers who want legitScript-verified compounded GLP-1 with semaglutide and tirzepatide options.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results64
92
Real-world results64
97Price honesty20
97
Price honesty20
96Prescriber access44
96
Prescriber access44
88Formulary choice40
88
Formulary choice40
95Cancellation fairness56
95
Cancellation fairness56
93Member support54
93
Member support54
Price, coverage & features
| Metric | CoreAge Rx | Vital Harmony Rx |
|---|---|---|
| Verdict Score | 94/100 | 46/100 |
| Grade | A | C |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | Not disclosed |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Vital Harmony Rx
What we like
- Verified LegitScript certification (ID 49230211) — a trust signal many compounded-GLP-1 DTC brands lack
- Explicit compounded-medication + 'not a pharmacy/manufacturer' disclosure on-site
- Both a semaglutide (GLP-1+B12) and a tirzepatide (GLP-1/GIP+B12) option
- Operates on a named physician network (Beluga Health)
The caveats
- NO pricing published anywhere on the site — a major gap for a cost-comparison directory; buyers cannot evaluate value without contacting the company
- No specific state list (only 'entire country' claimed)
- No named compounding pharmacy partner
- No named medical director / PIC, no legal entity or governing law disclosed
- Molecule strengths/dose tiers not published
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want legitScript-verified compounded GLP-1 with semaglutide and tirzepatide options.
Visit Vital Harmony Rx Read the full Vital Harmony Rx review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Vital Harmony Rx does the reverse.
More on CoreAge Rx
More on Vital Harmony Rx
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.